SRC and breast carcinoma: The overexpression, activation, or deregulation of SRC and other family members of the SFKs has been associated with different solid tumors (reviewed by Martellucci et al. in [37]), including, for example, ovarian cancer [39,40] and breast cancer [41,42,43].